Scotts Miracle-Gro Company (SMG)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $3.72B
Last updated: Nov 17, 2026 at 11:06 AM ET
Scotts Miracle-Gro Company (SMG) Financials: Revenue, Profit and Cash Flow
Scotts Miracle-Gro Company reported revenue of $3.41B for the fiscal year ended Sep 30, 2025, down 3.9% from the year before. That year, net income was $145.20M with a net margin of 4.3%, operating cash flow was $371.30M and free cash flow was $273.90M. The quarter ended Jun 30, 2026 had revenue of $1.17B and net income of $112.20M.
Revenue and Margins
The operating margin was 10.5% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $2.51B, a compound annual rate of 3.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $3.41B | -3.9% | 30.6% | 10.5% | 4.3% |
| Sep 2024 | $3.55B | 0.0% | 23.9% | 5.9% | -1.0% |
| Sep 2023 | $3.55B | -9.5% | 18.5% | -4.9% | -10.7% |
| Sep 2022 | $3.92B | -20.3% | 22.2% | -11.1% | -11.1% |
| Sep 2021 | $4.92B | +19.2% | 29.8% | 14.7% | 10.4% |
| Sep 2020 | $4.13B | +30.9% | 32.6% | 14.2% | 9.4% |
| Sep 2019 | $3.16B | +18.5% | 32.3% | 13.0% | 14.6% |
| Sep 2018 | $2.66B | +0.8% | 32.5% | 7.5% | 2.4% |
| Sep 2017 | $2.64B | +5.4% | 36.8% | 16.4% | 8.3% |
| Sep 2016 | $2.51B | N/A | 35.9% | 17.9% | 12.6% |
Income Statement
In the fiscal year ended Sep 2025, net income turned positive after a loss the year before. In the quarter ended Jun 2026, net income fell 24.7% from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.41B | $3.55B | $3.55B | $3.92B | $4.92B | $4.13B | $3.16B | $2.66B | $2.64B | $2.51B |
| Cost of revenue | $2.37B | $2.70B | $2.89B | $3.05B | $3.46B | $2.78B | $2.14B | $1.80B | $1.67B | $1.61B |
| Gross profit | $1.04B | $850.50M | $657.30M | $872.90M | $1.47B | $1.35B | $1.02B | $864.60M | $972.60M | $900.30M |
| Operating income | $358.60M | $208.80M | -$174.40M | -$434.00M | $723.00M | $585.20M | $409.60M | $198.90M | $433.40M | $447.60M |
| Net income | $145.20M | -$34.90M | -$380.10M | -$437.50M | $513.40M | $388.60M | $460.20M | $63.70M | $218.80M | $314.80M |
| EBITDA | $428.30M | $283.90M | -$81.60M | -$321.90M | $835.40M | $700.00M | $769.40M | $280.60M | $500.10M | $521.10M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.46B | $354.40M | $387.30M | $1.16B | $1.39B | $366.60M | $414.70M | $1.20B | $1.53B | $410.40M | $374.50M |
| Gross profit | $365.90M | $610.50M | $88.70M | $23.50M | $372.70M | $542.10M | $88.50M | -$29.50M | $354.10M | $463.70M | $62.20M | -$57.00M |
| Operating income | $169.60M | $401.80M | -$21.80M | -$150.10M | $221.80M | $349.70M | -$45.80M | -$216.10M | $200.10M | $272.10M | -$47.30M | -$416.10M |
| Net income | $112.20M | $238.60M | -$125.00M | -$151.90M | $149.10M | $217.50M | -$69.50M | -$244.00M | $132.10M | $157.50M | -$80.50M | -$468.50M |
Balance Sheet
As of Sep 2025, total debt of $2.11B exceeded cash and equivalents by $2.07B. Shareholder equity was negative, at -$357.50M, as total liabilities of $3.10B exceeded total assets of $2.74B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.74B | $2.87B | $3.41B | $4.30B | $4.80B | $3.38B | $3.03B | $3.05B | $2.75B | $2.76B |
| Current assets | $940.30M | $980.40M | $1.40B | $1.98B | $2.02B | $1.22B | $1.04B | $885.70M | $881.70M | $1.03B |
| Cash and equivalents | $32.80M | $71.60M | $31.90M | $86.80M | $244.10M | $16.60M | $18.80M | $33.90M | $120.50M | $28.60M |
| Total liabilities | $3.10B | $3.26B | $3.68B | $4.15B | $3.79B | $2.68B | $2.31B | $2.69B | $2.09B | $2.02B |
| Short-term debt | $57.20M | $52.60M | $52.30M | $144.30M | $57.80M | $66.40M | $128.10M | $132.60M | $143.10M | $185.00M |
| Long-term debt | $2.05B | $2.17B | $2.56B | $2.83B | $2.24B | $1.46B | $1.52B | $1.88B | $1.26B | $1.03B |
| Shareholder equity | -$357.50M | -$390.60M | -$267.30M | $147.70M | $1.01B | $697.20M | $718.70M | $354.60M | $648.80M | $715.20M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.17B | $3.41B | $3.03B | $2.74B | $3.09B | $3.54B | $3.17B | $2.87B | $3.49B | $3.92B | $3.72B | $3.41B |
| Total liabilities | $3.38B | $3.70B | $3.53B | $3.10B | $3.26B | $3.83B | $3.65B | $3.26B | $3.64B | $4.18B | $4.10B | $3.68B |
| Cash and equivalents | $27.70M | $6.20M | $8.30M | $36.60M | $39.60M | $8.70M | $5.70M | $71.60M | $279.90M | $65.10M | $10.40M | $31.90M |
| Shareholder equity | -$208.70M | -$286.50M | -$500.60M | -$357.50M | -$170.90M | -$290.10M | -$479.50M | -$390.60M | -$146.20M | -$250.90M | -$385.40M | -$267.30M |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 73.8% of operating cash flow. Dividends and share repurchases together came to 63.1% of it.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $371.30M | $667.50M | $531.00M | -$129.00M | $271.50M | $558.00M | $226.80M | $342.50M | $363.20M | $244.00M |
| Capital expenditures | $97.40M | $84.00M | $92.80M | $113.50M | $106.90M | $62.70M | $42.40M | $68.20M | $69.60M | $58.30M |
| Free cash flow | $273.90M | $583.50M | $438.20M | -$242.50M | $164.60M | $495.30M | $184.40M | $274.30M | $293.60M | $185.70M |
| Dividends paid | $154.30M | $151.30M | $149.10M | $166.20M | $143.00M | $411.20M | $124.50M | $120.00M | $128.40M | $116.60M |
| Share repurchases | $18.40M | $5.10M | $9.30M | $257.90M | $129.30M | $53.20M | $3.10M | $398.40M | $255.20M | $137.40M |
| Investing cash flow | -$112.10M | -$100.40M | -$65.70M | -$283.20M | -$538.60M | $46.90M | $255.20M | -$580.70M | $22.40M | -$134.40M |
| Financing cash flow | -$294.00M | -$527.90M | -$520.10M | $255.30M | $494.00M | -$607.10M | -$496.50M | $151.20M | -$316.80M | -$128.80M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $345.60M | $220.00M | -$370.40M | $174.10M | $454.40M | $188.10M | -$445.30M | $118.50M | $588.00M | $304.20M | -$343.20M | $535.30M |
| Capital expenditures | $24.50M | $18.60M | $20.00M | $42.90M | $16.90M | $8.30M | $29.30M | $16.60M | $13.20M | $16.30M | $37.90M | $19.00M |
| Free cash flow | $321.10M | $201.40M | -$390.40M | $131.20M | $437.50M | $179.80M | -$474.60M | $101.90M | $574.80M | $287.90M | -$381.10M | $516.30M |
Frequently Asked Questions About SMG
What is Scotts Miracle-Gro Company's annual revenue?
Scotts Miracle-Gro Company reported revenue of $3.41B for the fiscal year ended Sep 30, 2025.
How fast is Scotts Miracle-Gro Company's revenue growing?
Revenue was down 3.9% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.5%.
Is Scotts Miracle-Gro Company profitable?
Yes. Scotts Miracle-Gro Company reported net income of $145.20M for the fiscal year ended Sep 30, 2025, with a net margin of 4.3%.
How much free cash flow does SMG generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $371.30M minus capital expenditures of $97.40M produced free cash flow of $273.90M.
How much debt does Scotts Miracle-Gro Company have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $2.05B, short-term debt of $57.20M and cash and equivalents of $32.80M.
SMG pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors